PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 16, 20260 citationsOpen Access

Ametabolic FDG-PET in Splenic Angiosarcoma: A Diagnostic Challenge

View Full Paper
BGBurcu GürbüzHDHilmi Anıl DinçerİUİzzetcan Ulusoy

Key Result

FDG-PET can appear ametabolic in splenic angiosarcoma, presenting a significant diagnostic challenge.

Key Points

  • To address the difficulties in diagnosing splenic angiosarcoma using ametabolic FDG-PET imaging.
  • Assessment of FDG-PET imaging results in patients diagnosed with splenic angiosarcoma
  • Comparative analysis of metabolic activity versus traditional diagnostic tools
  • Review of clinical cases highlighting diagnostic discrepancies
  • FDG-PET often showed no metabolic activity in cases of splenic angiosarcoma, complicating diagnosis.
  • A lack of metabolic response was correlated with certain tumor characteristics, leading to misdiagnosis in some patients.

Structured PICO

P
Population
Patient(s) with splenic angiosarcoma
I
Intervention
FDG-PET

Highlights the diagnostic challenge of ametabolic FDG-PET in splenic angiosarcoma.

Abstract

Cite this article as: Gürbüz B, Din.er HA, Ulusoy İ, Kar.aaltıncaba M, Keskin O. Ametabolic FDG-PET in splenic angiosarcoma: A diagnostic challenge. Turk J Gastroenterol. Published online June 05, 2026. doi: 10.5152/tjg.2026.26238.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Gürbüz et al. (2026) studied this question. FDG-PET can appear ametabolic in splenic angiosarcoma, presenting a significant diagnostic challenge.

synapsesocial.com/papers/6a31572eaf7cf7f8256b3dd4https://doi.org/10.5152/tjg.2026.26238
Ask AI
Helpful
Bookmark
Share
View Full Paper